Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DSM-Firmenich is a global leader in health, nutrition, beauty and bioscience. Formed from the merger of Royal DSM and Firmenich in May 2023, it combines expertise in biotechnology-driven ingredient innovation with world-class manufacturing. The company supplies vitamins, carotenoids, nutritional lipids/proteins/enzymes/peptides/fragrances/flavors/specialty excipients/APIs to food & beverage manufacturers as well as pharmaceutical and personal care companies. It does not develop its own drugs but enables partners’ therapies by providing high-quality functional ingredients—such as taste modulators or bioactive compounds—and technical support throughout formulation development. Recent innovations include award-winning biotech skincare actives like ETERWELL™ YOUTH bio-active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSM-Firmenich.